In this article, we discuss 5 stocks to buy according to William Dollens’ Global Frontier Investments. If you want our detailed analysis of William Dollens’ history, investment philosophy, and hedge fund performance, go directly to 10 Stocks To Buy According To William Dollens’ Global Frontier Investments.
5. KKR & Co. Inc. (NYSE:KKR)
Global Frontier Investments’ Stake Value: $6,088,000
Percentage of Global Frontier Investments’ 13F Portfolio: 4.44%
Number of Hedge Fund Holders: 56
William Dollens’ Global Frontier Investments, as of the end of September this year, owns 100,000 shares in KKR & Co. Inc. (NYSE:KKR), worth $6.08 million, representing 4.44% of the firm’s Q3 investment portfolio. KKR & Co. Inc. (NYSE:KKR) is a global investment company dealing in private equity, real estate, credit, energy, and infrastructure via partnerships with hedge funds. KKR & Co. Inc. (NYSE:KKR) is one of the top stocks in William Dollens’ portfolio for the third quarter.
KKR & Co. Inc. (NYSE:KKR)’s Q3 EPS came in at $1.05, beating estimates by $0.10 on November 2. Revenue for the quarter also exceeded expectations by $108.92 million at $818.58 million.
At the end of the third quarter, 56 out of the 867 hedge funds tracked by Insider Monkey were bullish on KKR & Co. Inc. (NYSE:KKR), up from 54 in Q2.
Deutsche Bank analyst Brian Bedell on November 3 raised the price target from $75 to $87, and kept a Buy rating on KKR & Co. Inc. (NYSE:KKR), owing to strong Q3 results.
Here is what Vulcan Value Partners has to say about KKR & Co. Inc. (NYSE:KKR) in its Q2 2021 investor letter:
“KKR & Co. Inc. was also a material contributor during the quarter. This company has deep and growing relationships with capital providers. The company has a stable management fee stream and a proven ability to convert investor capital into a performance fee stream. These attributes contribute to its stable and growing intrinsic values. In addition, the company enjoys nice tailwinds of increasing allocations to private and alternative investments. We are pleased to continue to own KKR & Co.”
4. Alibaba Group Holding Limited (NYSE:BABA)
Global Frontier Investments’ Stake Value: $7,402,000
Percentage of Global Frontier Investments’ 13F Portfolio: 5.40%
Number of Hedge Fund Holders: 115
Alibaba Group Holding Limited (NYSE:BABA) is one of the most popular stocks in Global Frontier Investments’ portfolio at the end of September this year. William Dollens owns 50,000 shares in Alibaba Group Holding Limited (NYSE:BABA), worth $7.40 million, representing 5.40% of Dollens’ 13F portfolio. Alibaba Group Holding Limited (NYSE:BABA) is a Chinese multinational tech corporation that is a leading player in the e-commerce, retail, and internet sectors.
As of the end of the third quarter of 2021, 115 hedge funds tracked by Insider Monkey’s database of exclusive funds were bullish on Alibaba Group Holding Limited (NYSE:BABA), up from 146 in the prior quarter.
Jiong Shao, a Barclays analyst, on November 2 initiated coverage of Alibaba Group Holding Limited (NYSE:BABA) with a $275 price target and an Overweight rating. The Chinese tech sector is too good of an investment to pass up, according to Shao, and Alibaba Group Holding Limited (NYSE:BABA) has the most compelling valuation among the companies observed by Barclays.
Here is what Polen Capital Management has to say about Alibaba Group Holding Limited (NYSE:BABA) in its Q2 2021 investor letter:
“Alibaba also detracted from performance as the company continues to remain under regulatory scrutiny from both the Chinese State Administration for Market Regulation on antitrust concerns and the U.S. Securities and Exchange Commission on ADR listing requirements. Despite the regulatory overhang, we believe that Alibaba’s competitive positioning and growth outlook remains intact, even if the company must pay fines or modify some business practices. We viewed the current valuation at <20x next twelve month’s earnings as a compelling opportunity to add to our position. Alibaba is the second largest position in the Portfolio.”
3. Western Alliance Bancorporation (NYSE:WAL)
Global Frontier Investments’ Stake Value: $13,058,000
Percentage of Global Frontier Investments’ 13F Portfolio: 9.52%
Number of Hedge Fund Holders: 29
An Arizona-based banking company, Western Alliance Bancorporation (NYSE:WAL) is one of the top stocks in William Dollens’ portfolio for the third quarter of 2021. Global Frontier Investments owns 120,000 shares in Western Alliance Bancorporation (NYSE:WAL), valued at $13.05 million, representing 9.52% of the firm’s portfolio at the end of September. With a portfolio of assets worth $50 billion, Western Alliance Bancorporation (NYSE:WAL) is one of the top-tier American banks, operating nationwide. Western Alliance Bancorporation (NYSE:WAL) specializes in customized loans, mortgage, deposit, and treasury management services.
Western Alliance Bancorporation (NYSE:WAL), on October 21, announced earnings for the third quarter. The Q3 EPS was valued at $2.30, beating estimates by $0.05.
Truist analyst Brandon King, on October 25, raised the firm’s price target from $114 to $140, while keeping a Buy rating on Western Alliance Bancorporation (NYSE:WAL), owing to the Q3 earnings beat. The bank holding company is adding more products to its portfolio via strategic acquisitions, which will result in long-term growth potential.
At the end of September, 29 hedge funds were bullish on Western Alliance Bancorporation (NYSE:WAL), up from 28 in the preceding quarter.
2. Berkshire Hathaway Inc. (NYSE:BRK-A)
Global Frontier Investments’ Stake Value: $13,576,000
Percentage of Global Frontier Investments’ 13F Portfolio: 9.90%
Number of Hedge Fund Holders: 106
Billionaire Warren Buffett’s Berkshire Hathaway Inc. (NYSE:BRK-A) is one of William Dollens’ Global Frontier Investments’ top stock picks. Global Frontier Investments owns a $13.5 million stake in Berkshire Hathaway Inc. (NYSE:BRK-A), which represents 9.90% of the firm’s investment portfolio for the third quarter of 2021. Apart from owning popular companies, the conglomerate also has majority stakes in The Kraft Heinz Company (NASDAQ:KHC), American Express Company (NYSE:AXP), The Coca-Cola Company (NYSE:KO), Bank of America Corporation (NYSE:BAC), and Apple Inc. (NASDAQ:AAPL).
As of the third quarter of 2021, 106 hedge funds tracked by Insider Monkey’s database of elite funds reported owning stakes in Berkshire Hathaway Inc. (NYSE:BRK-A). This is compared to 116 funds holding stakes in the company in the preceding quarter.
Here is what Black Bear Value Partners has to say about Berkshire Hathaway Inc. (NYSE:BRK-A) in its Q3 2021 investor letter:
“Please see the Q1 letter for our Berkshire on a Napkin investment exercise. We have written on it extensively and will save your eyeballs from extraneous reading. Berkshire is very cheap for owning such high-quality businesses and will continue to grind higher and compound value for us.”
1. JPMorgan Chase & Co. (NYSE:JPM)
Global Frontier Investments’ Stake Value: $40,104,000
Percentage of Global Frontier Investments’ 13F Portfolio: 29.26%
Number of Hedge Fund Holders: 101
JPMorgan Chase & Co. (NYSE:JPM), a financial services and investment banking company from New York, is the largest holding in William Dollens’ Global Frontier Investments’ Q3 portfolio. The investment firm owns 245,000 shares worth $40.1 million in JPMorgan Chase & Co. (NYSE:JPM), representing 29.26% of Global Frontier Investments’ portfolio for the third quarter of 2021.
JPMorgan Chase & Co. (NYSE:JPM) reported earnings for Q3 on October 13, and the EPS for the quarter was $3.55, beating estimates by $0.55. JPMorgan Chase & Co. (NYSE:JPM)’s revenue also exceeded analysts’ estimates by $12.88 million at $29.65 billion.
Wells Fargo analyst Mike Mayo on October 25 raised the price target on JPMorgan Chase & Co. (NYSE:JPM) from $200 to $210, keeping an Overweight rating on the stock. Mayo was confident in the consistently delivered earnings of the investment banking company.
At the end of September, 101 hedge funds monitored by Insider Monkey reported owning stakes in JPMorgan Chase & Co. (NYSE:JPM), down from 108 in the previous quarter.
Here is what Vltava Fund has to say about JPMorgan Chase & Co. (NYSE:JPM) in its Q3 2021 investor letter:
“While all the previous names could be categorised as founder, continuing, or key shareholders, these last two names fall into the category of hired professional managers. This is actually the most numerous category among the bosses of large companies, but even among them there exist a number of individuals with exceptional long-term track records. In our view, these include also Jamie Dimon and Herman Gref.
We consider JP Morgan to be the strongest, largest, and most profitable bank in the world. It has not always been so, and the fact that it is what it is today can be attributed especially to its CEO Jamie Dimon. Dimon has spent his entire career in banking. He came to JP Morgan in a roundabout way in 2004 after the bank bought Bank One, of which he was CEO at the time. Since early 2006, Dimon has been CEO of the entire JP Morgan.
The quality and strength of JP Morgan under his leadership became fully apparent for the first time in 2008. Not only did JP Morgan help to stabilise the market by taking over the failing Bear Stearns in the spring of that year, but it was the only major US bank that did not require government assistance throughout the Great Financial Crisis and that was highly profitable even in the difficult year of 2008. Today, JP Morgan is even bigger, even more profitable, and even stronger than ever before. Many investors view banks with disdain, but a good bank with good management can be a very good long-term investment. From the time of its merger with Bank One in 2004 through the end of 2020, JP Morgan’s stock has outperformed even the S&P 500 index. The bank has earned a total net profit of USD 330 billion during this period, of which USD 232 billion has been paid out to shareholders in dividends and in share buybacks. I can recommend two books about Jamie Dimon: The House of Dimon and Last Man Standing.”
You can also take a look at 10 Earnings Reports Everyone is Talking About and 10 Cheap Pharmaceutical Stocks to Watch.
